{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:43:20Z","timestamp":1790253800468,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA00697356"],"award-info":[{"award-number":["P30 CA00697356"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA102184"],"award-info":[{"award-number":["R01 CA102184"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002224","name":"Melanoma Research Foundation","doi-asserted-by":"publisher","award":["P30 CA00697356"],"award-info":[{"award-number":["P30 CA00697356"]}],"id":[{"id":"10.13039\/100002224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017119","name":"Wistar Institute","doi-asserted-by":"publisher","award":["R01CA207935"],"award-info":[{"award-number":["R01CA207935"]}],"id":[{"id":"10.13039\/100017119","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017119","name":"Wistar Institute","doi-asserted-by":"publisher","award":["P01 CA114046"],"award-info":[{"award-number":["P01 CA114046"]}],"id":[{"id":"10.13039\/100017119","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017119","name":"Wistar Institute","doi-asserted-by":"publisher","award":["K99 CA208012-01"],"award-info":[{"award-number":["K99 CA208012-01"]}],"id":[{"id":"10.13039\/100017119","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017119","name":"Wistar Institute","doi-asserted-by":"publisher","award":["R01CA174746"],"award-info":[{"award-number":["R01CA174746"]}],"id":[{"id":"10.13039\/100017119","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Cell"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.molcel.2019.11.009","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T22:55:06Z","timestamp":1576018506000},"page":"633-644.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma"],"prefix":"10.1016","volume":"77","author":[{"given":"Marie R.","family":"Webster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell E.","family":"Fane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen M.","family":"Alicea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhasree","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew V.","family":"Kossenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria E.","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Douglass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett L.","family":"Ecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keerthana","family":"Gnanapradeepan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abibatou","family":"Ndoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Kugel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Valiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessicamarie","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangfan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgos C.","family":"Karakousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi K.","family":"Amaravadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara C.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe V.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito W.","family":"Rebecca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn M.","family":"Schuchter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenhard","family":"Herlyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen E.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashani T.","family":"Weeraratna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molcel.2019.11.009_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fonc.2018.00173","article-title":"Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance","volume":"8","author":"Ahmed","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.molcel.2019.11.009_bib2","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1158\/1535-7163.MCT-16-0535","article-title":"The Slow Cycling Phenotype: A Growing Problem for Treatment Resistance in Melanoma","volume":"16","author":"Ahn","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.molcel.2019.11.009_bib3","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1111\/febs.14040","article-title":"Targeting invasive properties of melanoma cells","volume":"284","author":"Arozarena","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.molcel.2019.11.009_bib4","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/onc.2013.57","article-title":"AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells","volume":"33","author":"Asiedu","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.molcel.2019.11.009_bib5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2019.11.009_bib6","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1158\/1078-0432.CCR-17-0201","article-title":"Inhibition of Age-Related Therapy Resistance in Melanoma by Rosiglitazone-Mediated Induction of Klotho","volume":"23","author":"Behera","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molcel.2019.11.009_bib7","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1186\/bcr2828","article-title":"The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expression","volume":"13","author":"Chan","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.molcel.2019.11.009_bib8","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/ng1651","article-title":"Probing tumor phenotypes using stable and regulated synthetic microRNA precursors","volume":"37","author":"Dickins","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molcel.2019.11.009_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-1-59745-249-6_12","article-title":"Detecting PKC phosphorylation as part of the Wnt\/calcium pathway in cutaneous melanoma","volume":"468","author":"Dissanayake","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.molcel.2019.11.009_bib10","doi-asserted-by":"crossref","first-page":"17259","DOI":"10.1074\/jbc.M700075200","article-title":"The Wnt5A\/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition","volume":"282","author":"Dissanayake","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.molcel.2019.11.009_bib11","doi-asserted-by":"crossref","first-page":"10205","DOI":"10.1158\/0008-5472.CAN-08-2149","article-title":"Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation","volume":"68","author":"Dissanayake","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.molcel.2019.11.009_bib12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1755-148X.2011.00871.x","article-title":"Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching","volume":"24","author":"Eichhoff","year":"2011","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.molcel.2019.11.009_bib13","doi-asserted-by":"crossref","first-page":"905","DOI":"10.15252\/msb.20166796","article-title":"Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de-differentiated state","volume":"13","author":"Fallahi-Sichani","year":"2017","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.molcel.2019.11.009_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.11.016","article-title":"The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage","volume":"21","author":"Gajjar","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2019.11.009_bib15","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.celrep.2017.10.052","article-title":"Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell Lines","volume":"21","author":"Garman","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.molcel.2019.11.009_bib16","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/j.bbamcr.2012.09.011","article-title":"SIAH-mediated ubiquitination and degradation of acetyl-transferases regulate the p53 response and protein acetylation","volume":"1823","author":"Grishina","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molcel.2019.11.009_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2019.11.009_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/1947601912454734","article-title":"The Regulation of Multiple p53 Stress Responses is Mediated through MDM2","volume":"3","author":"Hu","year":"2012","journal-title":"Genes Cancer"},{"key":"10.1016\/j.molcel.2019.11.009_bib19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ccr.2012.04.027","article-title":"p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer","volume":"21","author":"Jackson","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2019.11.009_bib20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature17392","article-title":"sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance","volume":"532","author":"Kaur","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2019.11.009_bib21","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1126\/science.285.5434.1733","article-title":"A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy","volume":"285","author":"Komarov","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.molcel.2019.11.009_bib22","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.celrep.2017.10.021","article-title":"A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma","volume":"21","author":"Krepler","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.molcel.2019.11.009_bib23","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1038\/sj.onc.1207587","article-title":"Downregulation of beta-catenin by p53 involves changes in the rate of beta-catenin phosphorylation and Axin dynamics","volume":"23","author":"Levina","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.molcel.2019.11.009_bib24","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1097-2765(01)00241-6","article-title":"Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein","volume":"7","author":"Liu","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2019.11.009_bib25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0092-8674(92)90243-6","article-title":"Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53","volume":"70","author":"Livingstone","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2019.11.009_bib26","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ccell.2016.09.019","article-title":"Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1\/CDK1-Phosphorylated Nuclear iASPP","volume":"30","author":"Lu","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2019.11.009_bib27","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1101\/gad.886901","article-title":"ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage","volume":"15","author":"Maya","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.molcel.2019.11.009_bib28","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/pcmr.12498","article-title":"The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations","volume":"29","author":"Meeth","year":"2016","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.molcel.2019.11.009_bib29","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1038\/ncomms6712","article-title":"Low MITF\/AXL ratio predicts early resistance to multiple targeted drugs in melanoma","volume":"5","author":"M\u00fcller","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molcel.2019.11.009_bib30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejca.2017.06.033","article-title":"P53 and MITF\/Bcl-2 identified as key pathways in the acquired resistance of NRAS-mutant melanoma to MEK inhibition","volume":"83","author":"Najem","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.molcel.2019.11.009_bib31","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1158\/2159-8290.CD-13-0005","article-title":"Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2","volume":"3","author":"O\u2019Connell","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.molcel.2019.11.009_bib32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/onc.2017.341","article-title":"A slow-cycling subpopulation of melanoma cells with highly invasive properties","volume":"37","author":"Perego","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.molcel.2019.11.009_bib33","doi-asserted-by":"crossref","first-page":"10131","DOI":"10.1074\/jbc.M116.724781","article-title":"Modeling the Etiology of p53-mutated Cancer Cells","volume":"291","author":"Perez","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.molcel.2019.11.009_bib34","doi-asserted-by":"crossref","first-page":"9834","DOI":"10.1038\/s41598-017-10129-z","article-title":"CD271 determines migratory properties of melanoma cells","volume":"7","author":"Radke","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molcel.2019.11.009_bib35","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cell.2018.06.025","article-title":"Toward Minimal Residual Disease-Directed Therapy in Melanoma","volume":"174","author":"Rambow","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2019.11.009_bib36","doi-asserted-by":"crossref","first-page":"ra82","DOI":"10.1126\/scisignal.aab1111","article-title":"The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma","volume":"8","author":"Ramsdale","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.molcel.2019.11.009_bib37","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ccr.2013.05.003","article-title":"Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells","volume":"23","author":"Roesch","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2019.11.009_bib38","first-page":"2851","article-title":"p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors","volume":"5","author":"Rogel","year":"1985","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molcel.2019.11.009_bib39","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1128\/MCB.21.20.6768-6781.2001","article-title":"Down-regulation of beta-catenin by activated p53","volume":"21","author":"Sadot","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molcel.2019.11.009_bib40","first-page":"467","article-title":"Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells","volume":"11","author":"Satyamoorthy","year":"2000","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.molcel.2019.11.009_bib41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.molcel.2019.11.009_bib42","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2016.02.003","article-title":"Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy","volume":"29","author":"Smith","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2019.11.009_bib43","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1073\/pnas.1530509100","article-title":"Statistical significance for genomewide studies","volume":"100","author":"Storey","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molcel.2019.11.009_bib44","doi-asserted-by":"crossref","first-page":"13679","DOI":"10.1073\/pnas.1712064115","article-title":"Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance","volume":"114","author":"Su","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molcel.2019.11.009_bib45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.molcel.2019.11.009_bib46","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1083\/jcb.200303158","article-title":"Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation","volume":"162","author":"Topol","year":"2003","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.molcel.2019.11.009_bib47","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","article-title":"Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress","volume":"33","author":"Tsoi","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2019.11.009_bib48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13058-018-1044-5","article-title":"Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment","volume":"20","author":"Ungerleider","year":"2018","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.molcel.2019.11.009_bib49","doi-asserted-by":"crossref","first-page":"pe11","DOI":"10.1126\/scisignal.2004114","article-title":"A Wnt-er migration: the confusing role of \u03b2-catenin in melanoma metastasis","volume":"6","author":"Webster","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.molcel.2019.11.009_bib50","first-page":"244","article-title":"The Wnts of change: How Wnts regulate phenotype switching in melanoma","volume":"1856","author":"Webster","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molcel.2019.11.009_bib51","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/pcmr.12330","article-title":"Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells","volume":"28","author":"Webster","year":"2015","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.molcel.2019.11.009_bib52","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1535-6108(02)00045-4","article-title":"Wnt5a signaling directly affects cell\u00a0motility and invasion of metastatic melanoma","volume":"1","author":"Weeraratna","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2019.11.009_bib53","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/pcmr.12459","article-title":"The genomic landscape of cutaneous melanoma","volume":"29","author":"Zhang","year":"2016","journal-title":"Pigment Cell Melanoma Res."}],"updated-by":[{"DOI":"10.1016\/j.molcel.2020.01.005","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000}}],"container-title":["Molecular Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109727651930838X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109727651930838X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:50:16Z","timestamp":1778590216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109727651930838X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S109727651930838X"],"URL":"https:\/\/doi.org\/10.1016\/j.molcel.2019.11.009","relation":{},"ISSN":["1097-2765"],"issn-type":[{"value":"1097-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molcel.2019.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}